Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections
Authors: Robert A. Vigersky
Journal: Annals of Internal Medicine (2018)

Letters3 April 2018Continuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin InjectionsRobert A. Vigersky, MDRobert A. Vigersky, MDMedtronic Diabetes, Washington, DC (R.A.V.)Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L17-0730 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail TO THE EDITOR:Arguello and Freeby's editorial (1) about the DIAMOND (Multiple Daily Injections and Continuous Glucose Monitoring in Diabetes) trial notes the importance of pairing diabetes education and counseling with continuous glucose monitoring (CGM) in patients with type 2 diabetes mellitus (T2DM). However, the article cited to support this recommendation is a study by Allen and colleagues (2) that used blinded CGM for 3 days, not real-time CGM (RT-CGM) as stated by Arguello and Freeby (3). The implications are important for several reasons.First, using RT-CGM for 24 weeks may not be necessary to achieve significant reductions in hemoglobin ...References1. Arguello V, Freeby M. Continuous glucose monitoring in patients with type 2 diabetes receiving insulin injections: does this mean continuous glucose monitoring for everyone? Ann Intern Med. 2017;167:436-7. [PMID: 28828490]. doi:10.7326/M17-2121 LinkGoogle Scholar2. Allen NA, Fain JA, Braun B, Chipkin SR. Continuous glucose monitoring counseling improves physical activity behaviors of individuals with type 2 diabetes: a randomized clinical trial. Diabetes Res Clin Pract. 2008;80:371-9. [PMID: 18304674] doi:10.1016/j.diabres.2008.01.006 CrossrefMedlineGoogle Scholar3. Vigersky R, Shrivastav M. Role of continuous glucose monitoring for type 2 in diabetes management and research. J Diabetes Complications. 2017;31:280-7. [PMID: 27818105] doi:10.1016/j.jdiacomp.2016.10.007 CrossrefMedlineGoogle Scholar4. Fonda SJ, Salkind SJ, Walker MS, Chellappa M, Ehrhardt N, Vigersky RA. Heterogeneity of responses to real-time continuous glucose monitoring (RT-CGM) in patients with type 2 diabetes and its implications for application. Diabetes Care. 2013;36:786-92. [PMID: 23172975] doi:10.2337/dc12-1225 CrossrefMedlineGoogle Scholar5. Vigersky RA, Fonda SJ, Chellappa M, Walker MS, Ehrhardt NM. Short- and long-term effects of real-time continuous glucose monitoring in patients with type 2 diabetes. Diabetes Care. 2012;35:32-8. [PMID: 22100963] doi:10.2337/dc11-1438 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: Medtronic Diabetes, Washington, DC (R.A.V.)Disclaimer: Dr. Vigersky is an employee of Medtronic Diabetes.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L17-0730. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetailsSee AlsoContinuous Glucose Monitoring in Patients With Type 2 Diabetes Receiving Insulin Injections: Does This Mean Continuous Glucose Monitoring for Everyone? Vanessa Arguello and Matthew Freeby Metrics 3 April 2018Volume 168, Issue 7Page: 528KeywordsDisclosureGlucoseHemoglobinInsulinObservational studiesType 2 diabetes ePublished: 3 April 2018 Issue Published: 3 April 2018 Copyright & PermissionsCopyright © 2018 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...